Tempus AI (NASDAQ:TEM) Trading 4% Higher – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares traded up 4% during mid-day trading on Wednesday . The stock traded as high as $48.29 and last traded at $47.57. 3,538,763 shares were traded during trading, a decline of 29% from the average session volume of 4,976,978 shares. The stock had previously closed at $45.74.

Wall Street Analyst Weigh In

Several research analysts have weighed in on TEM shares. Wolfe Research downgraded Tempus AI from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Morgan Stanley upped their price objective on Tempus AI from $50.00 to $60.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Loop Capital cut their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Piper Sandler decreased their price target on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Finally, TD Cowen restated a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Stock Performance

The company’s fifty day moving average is $56.07 and its 200-day moving average is $51.45. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Insiders Place Their Bets

In related news, major shareholder Bradley A. Keywell sold 265,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the transaction, the insider now directly owns 15,218,365 shares of the company’s stock, valued at $534,164,611.50. This represents a 1.71 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Jennifer A. Doudna sold 1,320 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $90.00, for a total value of $118,800.00. Following the completion of the sale, the director now directly owns 36,011 shares of the company’s stock, valued at approximately $3,240,990. This represents a 3.54 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,598,969 shares of company stock worth $317,194,162.

Hedge Funds Weigh In On Tempus AI

Several hedge funds have recently made changes to their positions in the company. Operose Advisors LLC acquired a new position in Tempus AI in the 4th quarter worth approximately $25,000. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI in the third quarter worth $30,000. Farther Finance Advisors LLC acquired a new position in Tempus AI during the fourth quarter valued at $34,000. Prestige Wealth Management Group LLC boosted its holdings in Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC acquired a new stake in Tempus AI during the 4th quarter worth about $49,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.